These are JPMorgan’s top stocks for October

Published Mon, Oct 2 20231:59 PM EDTUpdated Mon, Oct 2 20232:43 PM EDT

JPMorgan added three new stocks to its list of top names for October, including a sports betting company that has had a massive rally since the start of the year. The bank updated its focus list in a Monday note to include DraftKings , Boston Scientific and Wynn Resorts . The focus list comprises the top ideas of the bank's equity analysts spanning growth, value and short investment strategies. DraftKings, which has soared more than 155% year to date, was added to the list as a growth idea, with analyst Joseph Greff setting a price target of $37. That implies a 25% upside from the stock's $29.44 close Friday afternoon. DKNG YTD mountain DraftKings ytd chart The analyst upgraded the stock to overweight from equal weight, citing "recent survey work, improved fundamentals, increased estimates, and upcoming investor day." Boston Scientific , which is up 13% this year, was also added to the list. The bank has a $60 price target, more than 13% above the stock's $52.80 close on Friday. Analyst Robbie Marcus cited the firm's strong long-range growth targets and positive predictive analytics as catalysts for a "multi-year pipeline driven growth cycle." On the other hand, Wynn Resorts, up 13% since January, was added to the list as a value strategy idea. The $142 price target is roughly 53% above where shares closed Friday at $92.41. The "Macau recovery [is] still intact despite extreme negative sentiment from China disrupting the share price performance. Recent note on WYNN's opportunity in UAE a bonus," Greff wrote. Returning names to the list include value stock General Motors , which is down 3% this year. Analyst Ryan Brinkman's $56 target price implies shares could rise nearly 70%. Since September, the automobile manufacturer has been the target of strikes from the United Auto Workers union, alongside Ford Motor and Stellantis . Roughly 25,000 workers in total have been involved in the walkout. Edgewise Therapeutics is another growth name. Analyst Tessa Romero's $26 price target implies shares could rise more than 353% from their Friday close of $5.73. Year to date, the stock is down more than 36%. JPMorgan also removed five names from the list, including Boyd Gaming , CarMax and Carvana . — CNBC's Michael Bloom contributed to this report.